We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current GHSI market cap is 10.38M. The company's latest EPS is USD 0.1239 and P/E is 65.70.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.66M | 2.73M | 3.19M | 2.79M | 3.34M |
| Operating Income | -1.71M | -11.37M | -1.46M | -1.01M | -772k |
| Net Income | -1.7M | -9.85M | 533k | -1.17M | 373k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 903k | 2.51M | 7.23M | 11.05M | 12.25M |
| Operating Income | -10.5M | -8.44M | -24.48M | -17.41M | -4.34M |
| Net Income | -10.88M | -8.51M | -24.75M | -15.86M | 158k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.23M | 21.69M | 14.42M | 13.47M | 12.88M |
| Total Liabilities | 1.73M | 8.52M | 5.94M | 6.23M | 5.18M |
| Total Equity | 26.5M | 7.92M | 8.48M | 7.24M | 7.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.88M | 9.86M | 23.46M | 21.69M | 11.92M |
| Total Liabilities | 845k | 1.35M | 1.16M | 8.52M | 3.77M |
| Total Equity | 12.03M | 8.52M | 22.3M | 7.92M | 8.15M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.08M | -7.45M | -1.88M | -2.29M | -3.05M |
| Investing | 4.99M | 4.99M | -2k | -4k | -4k |
| Financing | 9.95M | 14.27M | -5.25M | -5.25M | -5.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.03M | -8.01M | -10.65M | -7.45M | -4.37M |
| Investing | -171k | -35k | -31.01M | 4.99M | 16k |
| Financing | 16.65M | 5.45M | 37.23M | 14.27M | -5.19M |
| Market Cap | 10.38M |
| Price to Earnings Ratio | 65.70 |
| Price to Sales Ratio | 0.85 |
| Price to Cash Ratio | 1.63 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 1.28M |
| Average Volume (1 week) | 3.12k |
| Average Volume (1 Month) | 10.9k |
| 52 Week Change | 48.00% |
| 52 Week High | 10.75 |
| 52 Week Low | 5.0102 |
| Spread (Intraday) | 0.72 (8.85%) |
| Company Name | Guardion Health Sciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.guardionhealth.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
